Indicators like biomarkers that predict a clinical benefit, even if they aren't the benefit themselves. 4. The Ethics of Equipoise
This is the moral compass of clinical trials. is the genuine uncertainty within the medical community about which treatment is better. If we already know for a fact that Treatment A is superior to Treatment B, it is unethical to start a trial. We only experiment when there is a true "honest doubt" to resolve. Fundamental Concepts for New Clinical Trialists
We don’t randomize just to be fair; we do it to eliminate . Randomization ensures that both known and unknown factors (like genetics or lifestyle) are distributed evenly across groups. This allows us to say with confidence that any difference in outcomes is due to the intervention, not the baseline characteristics of the patients. 2. Blinding: Protecting the Data’s Integrity Indicators like biomarkers that predict a clinical benefit,
The main question the study is powered to answer (e.g., "Does this drug lower blood pressure?"). is the genuine uncertainty within the medical community
Additional data points (e.g., "Does it also improve quality of sleep?").